[go: up one dir, main page]

SE9301582D0 - Purification of plasma proteins - Google Patents

Purification of plasma proteins

Info

Publication number
SE9301582D0
SE9301582D0 SE19939301582A SE9301582A SE9301582D0 SE 9301582 D0 SE9301582 D0 SE 9301582D0 SE 19939301582 A SE19939301582 A SE 19939301582A SE 9301582 A SE9301582 A SE 9301582A SE 9301582 D0 SE9301582 D0 SE 9301582D0
Authority
SE
Sweden
Prior art keywords
pct
aqueous phase
detergent
sec
salt
Prior art date
Application number
SE19939301582A
Other languages
English (en)
Swedish (sv)
Inventor
*Isaksson Sven
*Winge Stefan
Original Assignee
Kabi Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kabi Pharmacia Ab filed Critical Kabi Pharmacia Ab
Priority to SE19939301582A priority Critical patent/SE9301582D0/xx
Publication of SE9301582D0 publication Critical patent/SE9301582D0/xx
Priority to AT94915731T priority patent/ATE205719T1/de
Priority to AU67634/94A priority patent/AU677332B2/en
Priority to EP94915731A priority patent/EP0700300B1/fr
Priority to US08/537,872 priority patent/US5817765A/en
Priority to DE69428356T priority patent/DE69428356T2/de
Priority to JP52470494A priority patent/JP3771935B2/ja
Priority to PCT/SE1994/000422 priority patent/WO1994026287A1/fr
Priority to ES94915731T priority patent/ES2164702T3/es
Priority to CA002161804A priority patent/CA2161804C/fr
Priority to PT94915731T priority patent/PT700300E/pt
Priority to NZ266234A priority patent/NZ266234A/en
Priority to DK94915731T priority patent/DK0700300T3/da
Priority to FI955306A priority patent/FI113779B/fi
Priority to NO19954428A priority patent/NO313084B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/79—Transferrins, e.g. lactoferrins, ovotransferrins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/30—Extraction; Separation; Purification by precipitation
    • C07K1/303—Extraction; Separation; Purification by precipitation by salting out
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8125—Alpha-1-antitrypsin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Treatments Of Macromolecular Shaped Articles (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
SE19939301582A 1993-05-07 1993-05-07 Purification of plasma proteins SE9301582D0 (sv)

Priority Applications (15)

Application Number Priority Date Filing Date Title
SE19939301582A SE9301582D0 (sv) 1993-05-07 1993-05-07 Purification of plasma proteins
DK94915731T DK0700300T3 (da) 1993-05-07 1994-05-06 Oprensning af plasmaproteiner
JP52470494A JP3771935B2 (ja) 1993-05-07 1994-05-06 水溶性血漿タンパク質の純化方法
ES94915731T ES2164702T3 (es) 1993-05-07 1994-05-06 Purificacion de proteinas plasmaticas.
EP94915731A EP0700300B1 (fr) 1993-05-07 1994-05-06 Purification de proteines plasmatiques
US08/537,872 US5817765A (en) 1993-05-07 1994-05-06 Purification of plasma proteins
DE69428356T DE69428356T2 (de) 1993-05-07 1994-05-06 Reinigung von plasmaproteinen
AT94915731T ATE205719T1 (de) 1993-05-07 1994-05-06 Reinigung von plasmaproteinen
PCT/SE1994/000422 WO1994026287A1 (fr) 1993-05-07 1994-05-06 Purification de proteines plasmatiques
AU67634/94A AU677332B2 (en) 1993-05-07 1994-05-06 Purification of plasma proteins
CA002161804A CA2161804C (fr) 1993-05-07 1994-05-06 Purification des proteines plasmatiques
PT94915731T PT700300E (pt) 1993-05-07 1994-05-06 Purificacao de proteinas do plasma
NZ266234A NZ266234A (en) 1993-05-07 1994-05-06 Process for purifying a plasma protein employing a salt to form vesicles containing virus-inactivating chemicals; the vesicles are then removed
NO19954428A NO313084B1 (no) 1993-05-07 1995-11-06 Fremgangsmåte for rensing av et vannopplöselig plasmaprotein
FI955306A FI113779B (fi) 1993-05-07 1995-11-06 Plasmaproteiinien puhdistus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE19939301582A SE9301582D0 (sv) 1993-05-07 1993-05-07 Purification of plasma proteins

Publications (1)

Publication Number Publication Date
SE9301582D0 true SE9301582D0 (sv) 1993-05-07

Family

ID=20389869

Family Applications (1)

Application Number Title Priority Date Filing Date
SE19939301582A SE9301582D0 (sv) 1993-05-07 1993-05-07 Purification of plasma proteins

Country Status (15)

Country Link
US (1) US5817765A (fr)
EP (1) EP0700300B1 (fr)
JP (1) JP3771935B2 (fr)
AT (1) ATE205719T1 (fr)
AU (1) AU677332B2 (fr)
CA (1) CA2161804C (fr)
DE (1) DE69428356T2 (fr)
DK (1) DK0700300T3 (fr)
ES (1) ES2164702T3 (fr)
FI (1) FI113779B (fr)
NO (1) NO313084B1 (fr)
NZ (1) NZ266234A (fr)
PT (1) PT700300E (fr)
SE (1) SE9301582D0 (fr)
WO (1) WO1994026287A1 (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9500724D0 (sv) 1994-06-23 1995-02-24 Pharmacia Ab Filtrering
ES2099678B1 (es) * 1995-11-03 1998-02-16 Grifols Grupo Sa Procedimiento para la inactivacion de virus en proteinas.
US6518406B1 (en) 1999-06-23 2003-02-11 Octapharma Ag Method for purification of proteins
SE9902388D0 (sv) * 1999-06-23 1999-06-23 Pharmacia & Upjohn Ab Method for purification of proteins
DE19932782A1 (de) * 1999-07-14 2001-01-18 Biotest Pharma Gmbh Verfahren zur chromatographischen Fraktionierung von Plasma oder Serum, so erhaltene Präparate und deren Verwendung
AU2398801A (en) * 1999-12-20 2001-07-03 Mitsubishi Pharma Corporation Virus-free plasma protein compositions treated with porous membrane and process for producing the same
PL1654284T3 (pl) * 2003-08-12 2009-09-30 Octapharma Ag Sposób uzyskiwania roztworu alfa-1-antytrypsyny
WO2006011161A2 (fr) * 2004-06-29 2006-02-02 Reliance Life Sciences Pvt Ltd Procede d'amelioration de liquides biologiques exempts de virus
AU2005229674B2 (en) * 2004-11-18 2010-11-04 Kedrion Melville Inc. Low concentration solvent/detergent process of immuneglobulin with pre-treatment
WO2010033913A1 (fr) * 2008-09-22 2010-03-25 Icb International, Inc. Anticorps, analogues et leurs utilisations
US20100136584A1 (en) * 2008-09-22 2010-06-03 Icb International, Inc. Methods for using antibodies and analogs thereof
US8980610B2 (en) 2008-11-20 2015-03-17 Biogen Idec Ma Inc. Arginine inactivation of viruses
CN102812118B (zh) * 2010-04-08 2016-01-20 恰根有限公司 分离和纯化核酸的方法
EP2395082A1 (fr) 2010-06-14 2011-12-14 QIAGEN GmbH Extraction d'acides nucléiques à partir d'échantillons inclus dans de la cire
US8921062B2 (en) 2010-11-09 2014-12-30 Quest Diagnostics Investments Incorporated Diagnostic and prognostic assays based on circulating tyrosine kinase activity
US10112988B2 (en) 2012-01-09 2018-10-30 Icb International, Inc. Methods of assessing amyloid-beta peptides in the central nervous system by blood-brain barrier permeable peptide compositions comprising a vab domain of a camelid single domain heavy chain antibody against an anti-amyloid-beta peptide
US10112987B2 (en) 2012-01-09 2018-10-30 Icb International, Inc. Blood-brain barrier permeable peptide compositions comprising a vab domain of a camelid single domain heavy chain antibody against an amyloid-beta peptide
US9534029B2 (en) 2012-10-03 2017-01-03 Csl Behring Ag Method of purifying proteins
CA3129057C (fr) * 2012-10-03 2023-03-07 Csl Behring Ag Methode de purification des proteines
MX2020004151A (es) 2017-10-30 2020-08-13 Takeda Pharmaceuticals Co Detergentes compatibles con el medio ambiente para la inactivacion de virus envueltos en lipidos.
KR20220079572A (ko) * 2019-09-20 2022-06-13 플라즈마 테크놀로지스, 엘엘씨 치료 단백질 조성물 및 방법(therapeutic protein compositions and methods)
US10815270B1 (en) * 2019-09-20 2020-10-27 Plasma Technologies, Llc Compositions and methods for high efficiency protein precipitation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4820805A (en) * 1983-07-14 1989-04-11 New York Blood Center, Inc. Undenatured virus-free trialkyl phosphate treated biologically active protein derivatives
US4764369A (en) * 1983-07-14 1988-08-16 New York Blood Center Inc. Undenatured virus-free biologically active protein derivatives
US4540573A (en) * 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
US4684723A (en) * 1985-09-11 1987-08-04 Miles Laboratories, Inc. Method of separating proteins from aqueous solutions
US4789545A (en) * 1986-03-31 1988-12-06 New York Blood Center, Inc. Removal of lipid soluble process chemicals from biological materials by extraction with naturally occurring oils or synthetic substitutes thereof
ATE85221T1 (de) * 1988-11-05 1993-02-15 Octapharma Ag Verfahren zur herstellung eines hochreinen, nicht infektioesen antihaemophiliefaktors mittels chromatographie.
US5395923A (en) * 1993-02-23 1995-03-07 Haemacure-Biotech, Inc. Process for the obtention of a biological adhesive made of concentrated coagulation factors by "salting-out"

Also Published As

Publication number Publication date
JPH08509746A (ja) 1996-10-15
EP0700300A1 (fr) 1996-03-13
ES2164702T3 (es) 2002-03-01
EP0700300B1 (fr) 2001-09-19
DE69428356D1 (de) 2001-10-25
AU677332B2 (en) 1997-04-17
US5817765A (en) 1998-10-06
DK0700300T3 (da) 2001-12-31
FI113779B (fi) 2004-06-15
CA2161804A1 (fr) 1994-11-24
DE69428356T2 (de) 2002-04-25
NZ266234A (en) 1996-06-25
PT700300E (pt) 2002-03-28
CA2161804C (fr) 2003-12-02
NO954428L (no) 1995-11-06
AU6763494A (en) 1994-12-12
ATE205719T1 (de) 2001-10-15
FI955306A0 (fi) 1995-11-06
NO313084B1 (no) 2002-08-12
NO954428D0 (no) 1995-11-06
FI955306L (fi) 1995-11-06
WO1994026287A1 (fr) 1994-11-24
JP3771935B2 (ja) 2006-05-10

Similar Documents

Publication Publication Date Title
SE9301582D0 (sv) Purification of plasma proteins
DK0707594T3 (da) Adskillelse af proteiner
DE69832209D1 (de) Verfahren zur Herstellung von 3,3-Dimethylbutyraldehyd durch Oxidation von 3,3-Dimethylbutanol
NO20031471L (no) Glykoformer av faktor VII
ATE184884T1 (de) Fibrinogenkonzentrate aus blutplasma, verfahren und anlage für ihre herstellung
KR860008276A (ko) 단백질이 생성된 배양기로 부터 그것을 추출, 정제하는 방법
DK0634927T3 (da) Behandling og profylakse af sygdomme forårsaget af parasitter eller bakterier
NO964590L (no) Töyvaskemidler omfattende subtilisin BPN'-varianter
DE69535314D1 (de) Modifizierte pflanzenviren als vektore für heterologe peptide
DE69523161D1 (de) Salzlösung zur behandlung von kontaktlinsen
ATE235506T1 (de) Behandlung einer proteinlösung mit a1/fe und anschliesende membrankonzentration
ATE346088T1 (de) Kristallisierbare zusammensetzungen, die einen komplex von protease-domäne ns3 und ns4a aus dem hepatitis c virus enthalten, und damit bereitgestellte kristalle
EA199700221A1 (ru) Замещенный аминокислотой гидроксиэтиламиносульфонамид в качестве ингибиторов ретровирусной протеазы
FI911800A0 (fi) Enzymstabiliserande komposition och detergentkompositioner innehaollande ett stabiliserat enzym och en builder.
DE60330146D1 (de) Verfahren zur reinigung von fibrinogen
DE59308628D1 (de) Verfahren zur Herstellung von Faktor VIII
DK1329461T3 (da) Fremgangsmåde til fjernelse af humane serum-albumin-polymerer
DE3763601D1 (de) Verfahren zum isolieren und reinigen von haemin.
FI98642B (fi) Menetelmiä mikrobiologisesti tuotetun kymosiinin talteenottamiseksi
ES2196870T3 (es) Procedimiento para la purificacion o aislamiento de acidos nucleicos virales.
DE69811758D1 (de) Verwendung von Hyaluronsäure zur Herstellung einer wässrigen Lösung verwendbar als intra-artikulare Reinigungslösung
DK0512087T3 (da) Fremgangsmåde til reaktivering af denaturerede proteiner
JPS559036A (en) Purification of igm
DE60105760D1 (de) Verfahren zur behandlung von mitteln zur reinigung von abgasen
DE69426790D1 (de) Verfahren zur Fraktionierung von deacylierten Glycerophospholipiden